Bicara Therapeutics (BCAX) Prepaid Assets (2023 - 2026)
Bicara Therapeutics (BCAX) reported Prepaid Assets of $5.2 million for Q1 2026, down 40.59% on a YoY basis from $8.7 million in Q1 2025, and down 28.82% quarter-over-quarter from $7.3 million in Q4 2025.
Bicara Therapeutics (BCAX) Prepaid Assets (2023 - 2026) Analysis & Trends
Bicara Therapeutics has reported Prepaid Assets for 4 years, with the latest figure at $5.2 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 40.59% year-over-year to $5.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (down 40.59% YoY), and the FY2025 full-year result was $7.3 million, down 43.44% from the prior year.
- Prepaid Assets for Q1 2026 stood at $5.2 million, down from $7.3 million in the prior quarter.
- The five-year high for Prepaid Assets was $12.8 million in Q4 2024, with the low at $633000.0 in Q4 2023.
- Historically, Prepaid Assets has averaged $6.3 million across 4 years, with a median of $7.2 million in 2025.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 1925.59% — and 2025, when it slumped 43.44%.
- Bicara Therapeutics' Prepaid Assets stood at $633000.0 in 2023, then soared by 1925.59% to $12.8 million in 2024, then plunged by 43.44% to $7.3 million in 2025, then dropped by 28.82% to $5.2 million in 2026.
- The last three Prepaid Assets figures came in at $5.2 million (Q1 2026), $7.3 million (Q4 2025), and $7.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bicara Therapeutics | 1.41 Bn | 1.41 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.16 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 7.21 Mn |
| Jun 30, 2025 | 7.79 Mn |
| Mar 31, 2025 | 8.69 Mn |
| Dec 31, 2024 | 12.82 Mn |
| Sep 30, 2024 | 756,000.00 |
| Dec 31, 2023 | 633,000.00 |